Goal

Optogenerapy aims to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN- ß) protein delivery for treating patients suffering from multiple sclerosis

Impact

For Patients

Improve drug effectiveness
Improve compliance with drug taking

For System

Reduce direct and indirect costs
linked to Multiple Sclerosis

For Society

Social awareness of efficient therapies
improving patient compliance

Partners

eth_zurich
politechnika
erasmus
genexplan
ase-optics
neos_surgery
ultrasion
inserm
une
Do NOT follow this link or you will be banned from the site!